Fish & Richardson is scheduled to hold a webinar at 1:30 p.m. on Thursday titled, “FTC Challenges to Orange Book Listings: Considerations for Patent Holders.”

On Nov. 7, the Federal Trade Commission announced that it is challenging more than 100 patents held by 10 branded drug companies as improperly or inaccurately listed in the Food and Drug Administration’s Orange Book.